Controlling water release from a dimensionally stable aqueous composition

Patent metadata

Field	Value
Publication number	US-11752109-B2
Application number	US-201716071156-A
Country	US
Kind code	B2
Filing date	Jul 17, 2017
Priority date	Jan 20, 2016
Publication date	Sep 12, 2023
Grant date	Sep 12, 2023

Abstract

The invention relates to systems formed from closed liquid-tight packaging and a preferably dimensionally stable aqueous composition which is sealed therein and which, upon activation, releases a liquid phase essentially composed of water in a time-delayed manner. The invention further relates to methods for manufacturing such systems and the use thereof during the production of self-decomposing transdermal therapeutic systems (TTS).

First claim

The invention claimed is:

1. A system consisting of a closed, liquid-tight packaging, with an optional at least one mechanical means for opening, perforating or destroying the packaging;
wherein a hydrous composition is enclosed in said liquid-tight packaging, said hydrous composition comprising a sufficient amount of an activating agent, and
wherein a liquid phase is also enclosed within said closed liquid-tight packaging, and
wherein said liquid-tight packaging has at least one impervious seal whereby said impervious seal is facilitated by the release of said liquid phase consisting substantially of water that was released from the hydrous composition after a temporal delay;
the hydrous composition is a hydrogel based on a low-ester pectin or on a low-ester amidated pectin, and where the composition comprises as activating agent an alkaline earth or earth metal salt in an amount sufficient for the release of the liquid phase consisting substantially of water.

2. The system as claimed in claim 1 , wherein the closed, liquid-tight packaging is a film packaging.

3. The system as claimed in claim 1 , wherein the closed, liquid-tight packaging is a pouch.

4. The system as claimed in claim 1 , wherein said system includes at least one mechanical means for opening, perforating or destroying the packaging to facilitate the release of said liquid phase consisting substantially of water.

5. A method for producing a system as claimed in claim 1 , wherein the hydrous composition, an activating agent, and optionally at least one mechanical means for opening, perforating or destroying the packaging are placed into a liquid-tight packaging, and the liquid-tight is subsequently closed.

6. The system as claimed in claim 1 , wherein the hydrous composition is dimensionally stable.

7. The system as claimed in claim 1 , wherein the activating agent is a calcium salt.

8. The system as claimed in claim 1 , wherein the activating agent is calcium chloride.

9. The system as claimed in claim 3 , wherein the pouch is a sealed flat pouch.

10. A method for producing a system as claimed in claim 5 , wherein the liquid-tight packaging is film packaging and the packaging is closed by liquid-tight sealing.

11. The system as claimed in claim 9 , wherein said sealed flat pouch is either a three-edge sealed pouch or a four-edge sealed pouch.

12. The system as claimed in claim 1 , wherein said temporally delayed release of said liquid phase consisting substantially of water sets in from about 0.5 minute to about 10 hours thereby resulting in an impervious seal in said liquid-tight packaging.

13. The system as claimed in claim 1 , wherein the hydrogel is in the form of a wafer—polyester film laminate having two layers.

14. The system as claimed in claim 1 , wherein the hydrogel is a brittle gel.

15. The system as claimed in claim 1 , wherein said system does not comprise any active drug ingredient.

Assignees

• Lts Lohmann Therapie Systeme Ag

Inventors

• Hammes Florian
• EIFLER René

Classifications

• A61K9/703 Primary

  characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches · CPC title

• A61K9/7061 Primary

  Polyacrylates · CPC title

• A61K31/485

  Morphinan derivatives, e.g. morphine, codeine · CPC title

• A61P25/04

  Centrally acting analgesics, e.g. opioids · CPC title

• A61K9/0014

  Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title